Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVR118 in Advanced Malignancies
NCT00127517Phase 2Terminated
- Sponsor
- Advanced Viral Research Corp.
- Start
- Mar 2005
- Modality
- Peptides, Nucleic Acid Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer and cancer cachexia comparing AVR118 with Placebo (2 arms). Primary endpoint: Improvement in Quality of Life. Started Mar 2005; status: terminated.
02
Drugs
EOM613
03
Conditions
cancercancer cachexia
Beyond the preview
Go deeper on NCT00127517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127517.